Volume 2.22 | Jun 8

Mesenchymal Cell News 2.22, June 8, 2010.
In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  Events Subscribe  |  Unsubscribe


TOP STORY

Synovial Sarcoma is a Stem Cell Malignancy
Collectively, these data suggest that a human multipotent mesenchymal stem cell can serve as a cell of origin for synovial sarcoma (SS) and SS is a stem cell malignancy resulting from dysregulation of self-renewal and differentiation capacities driven by SS18-SSX fusion protein. [Stem Cells]

TeSR2_645x110_v01


CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

DNAJB6 Induces Degradation of Beta-Catenin and Causes Partial Reversal of Mesenchymal Phenotype
Researchers revealed that MRJ(L) expression causes changes in cell morphology concomitant with down-regulation of several mesenchymal markers viz. Vimentin, N-cadherin, Twist, Slug and up-regulation of epithelial marker, Keratin 18. [J Biol Chem]

Polyampholytes as Cryoprotective Agents for Mammalian Cell Cryopreservation
The results indicate that these polymeric extracellular cryoprotective agents (CPAs) may replace current CPAs and the high viability after thawing and non-necessity of serum ensure that these CPAs may be used in various preservation fields. [Cell Transplant]

Non-Senescent Hsp27-Upregulated MSCs Implantation Promote Neuroplasticity in Stroke Model
In this study, researchers demonstrated that implantation of human umbilical cord mesenchymal stem cells cultured in human umbilical cord serum significantly enhanced neuroplasticity and angiogenesis in stroke and ischemic limb models. [Cell Transplant]

Loss of Stromal Caveolin-1 Leads to Oxidative Stress, Mimics Hypoxia and Drives Inflammation in the Tumor Microenvironment, Conferring the “Reverse Warburg Effect”: A Transcriptional Informatics Analysis with Validation
Using an unbiased informatics analysis of the transcriptional profile of Cav-1 (-/-) deficient mesenchymal stromal cells, researchers have now identified many of the major signaling pathways that are activated by a loss of Cav-1, under conditions of metabolic restriction (with low glucose media). [Cell Cycle]

Promotion of Human Adipose-Derived Stem Cell Proliferation Mediated by Exogenous Nucleosides
The results support the importance of the nucleoside supplementation of media to improve conditions for the expansion and maintenance of human adipose-derived stem cells in culture. [Cell Biol Int]

Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-Versus-Host Disease: A Report of Two Cases
Here researchers have reported two cases of the patients with acute steroid-refractory graft-versus-host disease who underwent allogeneic hematopoietic stem cell transplantation. [Int J Hematol]


INDUSTRY NEWS

30 Johns Hopkins Researchers Receive Maryland Stem Cell Funding
Thirty Johns Hopkins researchers have been awarded funding from the Maryland Stem Cell Research Commission under the Maryland Stem Cell Research Act of 2006. [Johns Hopkins Medicine Press Release]

Costa Rica Puts Brakes on Popular Stem Cell Tourism
Costa Rica is cracking down on an unauthorized stem cell clinic that has attracted hundreds of foreigners seeking relief from degenerative diseases and serious injuries. [Reuters]

EU Merger Update
PTS, Inc. announced that it is preparing a Letter of Intent to merge with a European tissue engineering company. [PR Newswire]

Derma Sciences Receives CE Mark for ALGICELL(R) Ag
Derma Sciences, Inc. announced that its ALGICELL® Ag wound dressings have received a CE mark for use in the European Union. SGS Group, the world’s largest Control and Inspection Company, supervised the assessment and certification process. [PR Newswire]


POLICY NEWS

STAR METRICS: New Way to Measure the Impact of Federally Funded Research
A new initiative–Science and Technology for America’s Reinvestment: Measuring the Effect of Research on Innovation, Competitiveness and Science, or STAR METRICS–promises to monitor the impact of federal science investments on employment, knowledge generation, and health outcomes. [National Institutes of Health, United States]

Administrative Supplements to Increase Public Awareness of Pediatric Cancers and Available Treatments and Research (NOT-CA-10-026) [National Institutes of Health, United States]

Heart Failure Clinical Research Network Regional Clinical Centers (U10) (RFA-HL-12-001) [National Institutes of Health, United States]

FDA Announces Collaboration with Drugs.com
The U.S. Food and Drug Administration announced that it will collaborate with the website Drugs.com to expand access to the FDA’s consumer health information. [Food and Drug Administration, United States]

2010 Biological License Application Approvals [Food and Drug Administration, United States]

2010 Biological Device Application Approvals [Food and Drug Administration, United States]

Emerging Infectious Diseases: Evaluation to Implementation for Transfusion and Transplantation Safety Public Workshop (Update) [Food and Drug Administration, United States]


EVENTS

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – European Union 2010
June 13-17, 2010
Galway, Ireland

International Society for Stem Cell Research (ISSCR) 8th Annual Meeting
June 16-19, 2010
San Francisco, United States

United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference
July 12-14, 2010
Nottingham, United Kingdom

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010
September 15-17, 2010
Sydney, Australia

5th World Congress on Preventative and Regenerative Medicine (WCRM) 2010
October 5-7, 2010
Hannover, Germany

2010 American Society for Matrix Biology (ASMB) Meeting
October 24-27, 2010
Charleston, United States

52nd American Society of Hematology (ASH) Annual Meeting and Exposition
December 4-7, 2010
Orlando, United States

Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference
December 5-8, 2010
Orlando, United States

Visit our events page  to stay up to date with the latest events in the cell, gene and immunotherapy community.

JOB OPPORTUNITIES


Senior Scientist – Magnetic Cell Separation (STEMCELL Technologies)

Business Development Manager Europe – Cell Therapy Products (Pall Corporation)


Manager/Sr. Manager, Therapeutic Cell Solutions, Process Development (Lonza)

Sr. Product Support and Training Specialist (CardianBCT)

Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Mesenchymal Cell News.

Visit here to post your career opportunities.



Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!



Comments or Suggestions? Email [email protected] with your feedback.



Learn more about Mesenchymal Cell News: Archives  |  Events  |  Subscribe  |  Contact Us